Results 251 to 260 of about 1,043,723 (341)

Implementation and application of multiple potential natural vegetation models – a case study of Hungary

, 2017
I. Somodi, Z. Mólnar, B. Czúcz, Ákos Bede‐Fazekas, J. Bölöni, L. Pásztor, Annamária Laborczi, N. Zimmermann   +7 more
semanticscholar   +1 more source

How Amino Acids Intercalate in CaFe Layered Double Hydroxides: A Combined RIXS and NEXAFS Study

ChemPhysChem, Volume 26, Issue 6, March 15, 2025.
Intercalation of amino acids in layered double hydroxides offers a road to functional (bio)catalysts. With resonant soft x‐ray spectroscopy we probe the electronic structure of these systems and observe activation and passivation of electronic states as well as bond formation between the amino acid and the LDH upon intercalation.
R. Büchner, A. Born, K. Ruotsalainen, R. Decker, A. Pietzsch   +4 more
wiley   +1 more source

Physiotherapy for endometriosis-associated pelvic pain: a systematic review and meta-analysis. [PDF]

Pain Med
Can G, das Virgens IPA, Fehér B, Orbán EP, Fehérvári P, Bánhidy F, Hegyi P, Mayer ÁA, Ács N.   +8 more
europepmc   +1 more source

The Presence of Absence. Transgenerational Local Memory of the Holocaust Among Hungarians

Richárd Papp, György Csepeli
openalex   +2 more sources

Production and business processes [PDF]

, 2000
The Hungarian Technology Foresight Programme, Ministry of Education of the Republic of Hungary
core  

Lower Dose‐Normalized Tacrolimus Exposure in CYP3A5*6 vs. *3 Loss‐of‐Function Allele Carriers: A Longitudinal Retrospective Real‐World Study in Kidney Transplant Recipients

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacogenomic research has historically focused on individuals of European ancestry, leading to the underrepresentation of genetic variants common in non‐European populations. This bias is exemplified by CYP3A5*6, a functionally consequential variant common in individuals of African ancestry (MAF: 11–19%) but virtually absent in Europeans (MAF: 0.15%)
Amar D. Levens, Dirk Jan A. R. Moes, Yanick Boer, Aiko P. J. de Vries, Dorottya K. de Vries, Danny van der Helm, Soufian Meziyerh, Dave L. Roelen, Stefan Böhringer, Teun Van Gelder, Jesse J. Swen   +10 more
wiley   +1 more source

Experiences of the Development of a Revised, Population-Adjusted Communicative Health Literacy Scale. [PDF]

J Patient Exp
Szilágyi-Hornyák E, Nagy-Pénzes G, Mátyás G, Ádány R, Bíró É.   +4 more
europepmc   +1 more source

New Tasks of the Hungarian Military Intelligence Office after NATO Accession

, 2000
Laszlo Botz
openalex   +1 more source

The role of the convergent processes in the formation of the Hungarian language

Kuldashevа Shakhnoza Akramovna
openalex   +2 more sources

Quantitative Systems Toxicology Modeling with DILIsym to Support Phase 3 Dose Selection for Fezolinetant

Clinical Pharmacology &Therapeutics, EarlyView.
Fezolinetant is a first‐in‐class, selective, non‐hormonal, neurokinin 3 receptor antagonist that is approved for the treatment of moderate to severe vasomotor symptoms due to menopause. In a phase 2b clinical study (n = 352), nine study participants experienced elevations in serum transaminases exceeding three times the upper limit of normal.
Jace C. Nielsen, Jeffrey L. Woodhead, Brett A. Howell, Lisl K. M. Shoda, Dolly A. Parasrampuria, Jiayin Huang, Megumi Iwai, Faith D. Ottery, Xuegong Wang, Marci English, Kentaro Miyazaki, Paul B. Watkins   +11 more
wiley   +1 more source